lecanemab

Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment
Pharmaphorum
Mon, 08/26/24 - 10:14 am
Alzheimer's disease
physicians
Eli Lilly
Kisunla
donanemab
lecanemab
FDA sets July decision date for full approval of Leqembi
BioSpace
Mon, 03/6/23 - 12:11 pm
Eisai
Biogen
Alzheimer's disease
Leqembi
FDA
lecanemab
Eisai Anticipates Full Approval of Leqembi as Early as July
BioSpace
Mon, 02/20/23 - 12:44 pm
Eisai
FDA
Alzheimer's disease
Leqembi
lecanemab
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Motley Fool
Thu, 01/19/23 - 10:15 am
Biogen
Eisai
Alzheimer's disease
Leqembi
lecanemab
New Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s
Fierce Pharma
Fri, 01/13/23 - 10:59 am
Biogen
Chris Viehbacher
lecanemab
Alzheimer's disease
Pharma CEOs
Alzheimer’s disease trials: How does Lilly’s donanemab compare to lecanemab?
Clinical Trials Arena
Fri, 01/13/23 - 10:49 am
clinical trials
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Leqembi
lecanemab
donanemab
After FDA nod, Eisai and Biogen file lecanemab in EU
Pharmaphorum
Wed, 01/11/23 - 11:04 pm
Eisai
Biogen
lecanemab
Europe
Alzheimer's disease
Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy
BioPharma Dive
Sun, 01/8/23 - 10:04 pm
Eisai
Biogen
drug pricing
Leqembi
Alzheimer's disease
lecanemab
FDA approves Alzheimer’s drug from Eisai, Biogen in closely watched decision
BioPharma Dive
Fri, 01/6/23 - 03:40 pm
Eisai
Biogen
lecanemab
Leqembi
Alzheimer's disease
FDA
Eisai and Biogen’s latest Alzheimer’s drug needs to be cheaper than the last one, analysts say
Stat
Thu, 12/22/22 - 11:10 am
Biogen
Eisai
Alzheimer's disease
drug pricing
ICER
lecanemab
3rd patient death potentially tied to Eisai's Alzheimer's drug reported
Fierce Biotech
Thu, 12/22/22 - 11:05 am
Biogen
Eisai
Alzheimer's disease
clinical trials
patient deaths
lecanemab
CTAD 2022 – lecanemab data hold up, with a big but
EP Vantage
Thu, 12/1/22 - 07:01 pm
Biogen
Eisai
Alzheimer's disease
CTAD
lecanemab
clinical trials
What to make of Eisai and Biogen’s latest Alzheimer’s drug data
BioPharma Dive
Tue, 11/29/22 - 10:58 pm
Biogen
Eisai
Alzheimer's disease
lecanemab
Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal
Fierce Biotech
Mon, 11/28/22 - 07:51 pm
Biogen
Eisai
clinical trials
patient death
lecanemab
Alzheimer's disease
Lilly powers through final stretch in critical Alzheimer's race
Fierce Biotech
Tue, 11/1/22 - 07:02 pm
Eli Lilly
Alzheimer's disease
donanemab
lecanemab
Eisai
Eisai's Alzheimer's hopeful lecanemab may have contributed to patient death: report
Fierce Biotech
Mon, 10/31/22 - 10:30 am
Eisai
patient death
lecanemab
Alzheimer's disease
clinical trials
Biogen's Q3 revenue declines 10% as focus shifts to new Alzheimer's and ALS drug candidates
Endpoints
Tue, 10/25/22 - 11:05 am
Biogen
earnings
Alzheimer's disease
ALS
tofersen
lecanemab
Where Will Biogen Be in 5 Years?
Motley Fool
Thu, 10/20/22 - 10:39 am
Biogen
Aduhelm
lecanemab
Alzheimer's disease
M&A
Roche CEO Cautious on Alzheimer’s Trial Despite Eisai’s Success
Bloomberg
Wed, 10/19/22 - 10:35 am
Roche
Pharma CEOs
Severin Schwan
Alzheimer's disease
Eisai
gantenerumab
lecanemab
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
FDA
Biogen
Eisai
Alzheimer's disease
Gilead Sciences
HIV
Mirati Therapeutics
lung cancer
lecanemab
lenacapavir
adagrasib

Pages